L'Occitane International S.A.

SEHK:973 Stock Report

Market Cap: HK$46.6b

L'Occitane International Valuation

Is 973 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 973 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 973 (HK$31.65) is trading below our estimate of fair value (HK$41.89)

Significantly Below Fair Value: 973 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 973?

Other financial metrics that can be useful for relative valuation.

973 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.7x
Enterprise Value/EBITDA16.5x
PEG Ratio2.1x

Price to Earnings Ratio vs Peers

How does 973's PE Ratio compare to its peers?

The above table shows the PE ratio for 973 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average21.4x
2367 Giant Biogene Holding
26.4x21.8%HK$41.5b
1044 Hengan International Group
9.4x4.2%HK$28.6b
2145 Shanghai Chicmax Cosmetic
39.9x31.5%HK$19.9b
6896 Golden Throat Holdings Group
9.8xn/aHK$2.7b
973 L'Occitane International
63.3x29.5%HK$46.6b

Price-To-Earnings vs Peers: 973 is expensive based on its Price-To-Earnings Ratio (63.3x) compared to the peer average (21.4x).


Price to Earnings Ratio vs Industry

How does 973's PE Ratio compare vs other companies in the Asian Personal Products Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.5%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.5%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 973 is expensive based on its Price-To-Earnings Ratio (63.3x) compared to the Asian Personal Products industry average (24.6x).


Price to Earnings Ratio vs Fair Ratio

What is 973's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

973 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio63.3x
Fair PE Ratio41.5x

Price-To-Earnings vs Fair Ratio: 973 is expensive based on its Price-To-Earnings Ratio (63.3x) compared to the estimated Fair Price-To-Earnings Ratio (41.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 973 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentHK$31.65
HK$30.15
-4.8%
13.1%HK$37.35HK$23.24n/a10
Mar ’25HK$29.90
HK$28.95
-3.2%
13.9%HK$37.41HK$23.28n/a10
Feb ’25HK$25.10
HK$28.05
+11.8%
13.4%HK$36.86HK$23.18n/a10
Jan ’25HK$22.30
HK$26.42
+18.5%
17.0%HK$36.44HK$20.66n/a10
Dec ’24HK$18.76
HK$26.71
+42.4%
17.0%HK$36.73HK$20.83n/a10
Nov ’24HK$20.05
HK$27.91
+39.2%
13.0%HK$36.93HK$22.95n/a10
Oct ’24HK$23.40
HK$28.22
+20.6%
13.0%HK$36.28HK$22.57n/a11
Sep ’24HK$27.80
HK$27.92
+0.4%
14.6%HK$36.87HK$22.93n/a11
Aug ’24HK$24.10
HK$28.24
+17.2%
15.3%HK$37.46HK$23.30n/a10
Jul ’24HK$18.84
HK$27.93
+48.3%
15.2%HK$36.87HK$22.93n/a10
Jun ’24HK$21.45
HK$30.46
+42.0%
10.4%HK$35.64HK$25.50n/a10
May ’24HK$19.90
HK$30.69
+54.2%
11.7%HK$36.66HK$25.96n/a11
Apr ’24HK$19.60
HK$30.57
+56.0%
13.0%HK$38.94HK$25.64n/a11
Mar ’24HK$18.92
HK$30.25
+59.9%
14.2%HK$38.10HK$25.09HK$29.9011
Feb ’24HK$20.20
HK$31.93
+58.1%
15.3%HK$39.17HK$25.79HK$25.1012
Jan ’24HK$24.35
HK$33.60
+38.0%
14.5%HK$42.62HK$26.46HK$22.3012
Dec ’23HK$21.70
HK$32.85
+51.4%
14.3%HK$41.50HK$26.20HK$18.7612
Nov ’23HK$19.74
HK$33.00
+67.2%
13.8%HK$39.54HK$25.51HK$20.0512
Oct ’23HK$23.85
HK$34.16
+43.2%
8.1%HK$38.74HK$29.38HK$23.4011
Sep ’23HK$24.20
HK$34.82
+43.9%
7.9%HK$39.93HK$30.28HK$27.8011
Aug ’23HK$26.40
HK$35.56
+34.7%
7.8%HK$40.82HK$30.95HK$24.1011
Jul ’23HK$24.50
HK$35.21
+43.7%
7.0%HK$39.81HK$31.52HK$18.8411
Jun ’23HK$24.50
HK$35.93
+46.6%
5.1%HK$38.47HK$32.06HK$21.4511
May ’23HK$25.05
HK$36.19
+44.5%
7.3%HK$42.79HK$31.75HK$19.9012
Apr ’23HK$26.10
HK$37.39
+43.3%
6.0%HK$42.36HK$33.17HK$19.6010
Mar ’23HK$26.35
HK$38.18
+44.9%
5.0%HK$43.25HK$36.18HK$18.9210

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.